Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis in psoriasis
A Owczarczyk-Saczonek, D Purzycka-Bohdan… - … in Dermatology and …, 2020 - termedia.pl
Psoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin
resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It
occurs more often in patients with a more severe course of the disease. Obesity is specially
an independent risk factor and it is associated with a worse treatment outcome because of
the high inflammatory activity of visceral fatty tissue and the production of inflammatory
mediators involved in the development of both psoriasis and metabolic disorders. However …
resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It
occurs more often in patients with a more severe course of the disease. Obesity is specially
an independent risk factor and it is associated with a worse treatment outcome because of
the high inflammatory activity of visceral fatty tissue and the production of inflammatory
mediators involved in the development of both psoriasis and metabolic disorders. However …
Pathogenesis of psoriasis in the omic era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis in psoriasis
D Purzycka-Bohdan… - Postępy Dermatologii i …, 2020 - son.uni.lodz.pl
Psoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin
resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It
occurs more often in patients with a more severe course of the disease. Obesity is specially
an independent risk factor and it is associated with a worse treatment outcome because of
the high inflammatory activity of visceral fatty tissue and the production of inflammatory
mediators involved in the development of both psoriasis and metabolic disorders. However …
resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It
occurs more often in patients with a more severe course of the disease. Obesity is specially
an independent risk factor and it is associated with a worse treatment outcome because of
the high inflammatory activity of visceral fatty tissue and the production of inflammatory
mediators involved in the development of both psoriasis and metabolic disorders. However …
以上显示的是最相近的搜索结果。 查看全部搜索结果